Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

This study is ongoing, but not recruiting participants.

Study NCT00586651 Information provided by Cephalon

First Received: December 21, 2007 Last Updated: July 15, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2010
Estimated Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)